NCT01453374View on ClinicalTrials.gov

A Study of VIVITROL in the Prevention of Re-arrest and Re-incarceration

PHASE4CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

January 31, 2011

Primary Completion Date

May 31, 2014

Study Completion Date

May 31, 2014

Conditions
Opioid Dependence
Interventions
DRUG

VIVITROL 380mg

380 mg IM injection given once monthly

Trial Locations (1)

21201

Friends Research Institute, Baltimore

Sponsors

Lead Sponsor

Alkermes, Inc.
All Listed Sponsors
lead

Alkermes, Inc.

INDUSTRY